Yüklüyor......
The treatment of pediatric chronic myelogenous leukemia in the imatinib era
Childhood chronic myelogenous leukemia (CML) is a rare hematologic disease, with limited literature on the methods of treatment. Previously, allogeneic hematopoietic stem cell transplantation (HSCT) was considered the only curative treatment for this disease. Treatment with imatinib, a selective inh...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
The Korean Pediatric Society
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3120996/ https://ncbi.nlm.nih.gov/pubmed/21738540 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3345/kjp.2011.54.3.111 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|